Atıf Formatları
Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter? report of a multi-institutional experience
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. GUNDUZ Et Al. , "Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter? report of a multi-institutional experience," INDIAN JOURNAL OF CANCER , vol.52, no.4, pp.658-660, 2015

GUNDUZ, S. Et Al. 2015. Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter? report of a multi-institutional experience. INDIAN JOURNAL OF CANCER , vol.52, no.4 , 658-660.

GUNDUZ, S., BOZCUK, H. Ş., YILDIZ, M., Goksu, S., Uysal, M., ARSLAN, D., ... TATLI, A. M.(2015). Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter? report of a multi-institutional experience. INDIAN JOURNAL OF CANCER , vol.52, no.4, 658-660.

GUNDUZ, ŞEYDA Et Al. "Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter? report of a multi-institutional experience," INDIAN JOURNAL OF CANCER , vol.52, no.4, 658-660, 2015

GUNDUZ, ŞEYDA Et Al. "Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter? report of a multi-institutional experience." INDIAN JOURNAL OF CANCER , vol.52, no.4, pp.658-660, 2015

GUNDUZ, S. Et Al. (2015) . "Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter? report of a multi-institutional experience." INDIAN JOURNAL OF CANCER , vol.52, no.4, pp.658-660.

@article{article, author={ŞEYDA GÜNDÜZ Et Al. }, title={Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter? report of a multi-institutional experience}, journal={INDIAN JOURNAL OF CANCER}, year=2015, pages={658-660} }